You are here

ABTERRA BIOSCIENCES, INC.

Company Information
Address
11588 SORRENTO VALLEY RD STE 16
SAN DIEGO, CA 92121-1336
United States


https://abterrabio.com

Information

UEI: TYHDLNB65NJ1

# of Employees: 9


Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No



Award Charts




Award Listing

  1. Intelligent in silico antibody library design and optimization for therapeutic use

    Amount: $244,049.00

    Antibody discovery technologies have delivered life saving therapies over the past three decades, however, many challenging targets remain undrugged due to limitations of these technologies. Phage dis ...

    SBIRPhase I2021Department of Health and Human Services National Institutes of Health
  2. Software for sequencing human antibody proteins from polyclonal immune responses

    Amount: $1,551,492.00

    The natural immune response to foreign pathogens involves a complex coordination of cells, including an adaptive response to select and secrete antibodies into circulation. Individuals who have recove ...

    SBIRPhase II2021Department of Health and Human Services National Institutes of Health
  3. Immune repertoire sequencing: error correction, analysis, and visualization on the cloud

    Amount: $217,313.00

    Project SummaryAntibodies are vital molecules produced by the adaptive immune system, and are a critical component in identifying foreign agents for removal within an organism. Produced by B cells, an ...

    SBIRPhase I2020Department of Health and Human Services National Institutes of Health
  4. Alicanto: Proteogenomic discovery of single chain antibodies in llama

    Amount: $1,096,486.00

    Heavy chain-only antibodies (HCAbs) are a unique class of antibodies only produced in camelids and cartilagenous fish. Unlike conventional antibodies that consist of two heavy chains and two light cha ...

    SBIRPhase II2020Department of Health and Human Services National Institutes of Health
  5. Quorum: glycopeptide discovery via mass spectrometry and spectral networking

    Amount: $1,923,528.00

    Glycosylation is a pervasive modification estimated to modify more than 50% of human proteins and is a key component of host-pathogen interactions, adaptive and innate immunity, and therapeutic develo ...

    SBIRPhase II2020Department of Health and Human Services National Institutes of Health
  6. COMPREHENSIVE REAGENTS FOR IMMUNOPHENOTYPING RABBIT CELL-MEDIATED IMMUNITY.

    Amount: $540,608.00

    Infectious disease studies in tuberculosis and papillomavirus have shown humans and rabbits share similar pathology and rabbits are more phylogenetically similar to primates than rodents. The use of t ...

    SBIRPhase I2020Department of Health and Human Services National Institutes of Health
  7. Quorum:natural product discovery via mass spectrometry and molecular networking

    Amount: $193,466.00

    Project Summary Advances in genome miningand consequent realization of untapped microbial diversity has lead to renewed interest in natural productNPdiscoveryNPs are a rich source of therapeutic candi ...

    SBIRPhase I2018Department of Health and Human Services National Institutes of Health
  8. Alicanto:Proteogenomic discovery of single chain antibodies in llama

    Amount: $170,108.00

    Antibodies are a key component of the adaptive immune systemreleased in response to disease in order to target foreign molecular surfacesDue to their capacity for high target affinity and specificityt ...

    SBIRPhase I2018Department of Health and Human Services National Institutes of Health
  9. An integrated transcriptomic and proteomic approach to antibody sequencing and repertoire characterization

    Amount: $886,819.00

    Antibodies are ideal drug candidates due to their high specificity for targetmoleculesMonoclonal antibodies represent one of the fastest growing segments ofthe drug markethoweverrecent attention has f ...

    SBIRPhase II2017Department of Health and Human Services National Institutes of Health
  10. Valens-Poly Sequencing Polyclonal Antibodies for Drug Discovery

    Amount: $652,895.00

    DESCRIPTION provided by applicant Antibodies are ideal drug candidates due to high specificity for target molecules Monoclonal antibodies represent one of the fastest growing segments of the drug ...

    SBIRPhase II2015Department of Health and Human Services National Institutes of Health
US Flag An Official Website of the United States Government